India  

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Video Credit: Wochit Entertainment - Duration: 00:35s - Published
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies.

The FDA officially announced the medicine could be used in treating COVID-19 patients.

Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals.

Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients.

It could shorten satsy by several days, reports Gizmodo.


You Might Like


Related videos from verified sources

Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient [Video]

Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient

Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug that’s shown success in reducing the duration of some COVID-19 cases.

Credit: Geo Beats     Duration: 00:45Published